Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer

Stephen G. Swisher, Mary Maish, Jeremy J. Erasmus, Arlene M. Correa, Jaffer A. Ajani, Robert Bresalier, Ritsuko Komaki, Homer Macapinlac, Reginald F. Munden, Joe B. Putnam, David Rice, W. Roy Smythe, Ara A. Vaporciyan, Garrett L. Walsh, Tsung T. Wu, Jack A. Roth

Research output: Contribution to journalArticlepeer-review

266 Scopus citations


Background This study evaluates the utility of positron emission tomography (PET), endoscopic ultrasonography (EUS), and computed tomographic (CT) scans to predict pathologic response and survival following preoperative chemoradiation (CRT) in esophageal cancer. Methods One hundred three sequential patients with locoregionally advanced esophageal cancer, who were treated with CRT and esophageal resection between May 2001 and November 2003 at the University of Texas M.D. Anderson Cancer Center, were retrospectively reviewed. PET, EUS, and CT were performed before (pre) or after (post) CRT and before surgical resection. PET standardized uptake value (SUV) was defined as maximal uptake in primary tumor. Results Most patients were male (91 [88%]) with adenocarcinoma (90 [87%]). Pretreatment clinical stages were: IIA (42 [41%]), IIB (5 [5%]), III (50 [49%]), and IVA (6 [6%]). At the time of surgery, 58 patients (56%) had a pathologic response to CRT (≤10% viable cells). Post-CRT measurements that correlated with pathologic response were: CT esophageal wall thickness (13.3 vs 15.3 mm, p = 0.04), EUS mass size (0.7 vs 1.7 cm, p = 0.01) and PET SUV (3.1 vs 5.8, p = 0.01). Post-CRT PET SUV equal to or greater than 4 had the highest accuracy for pathologic response (76%). Univariate and multivariate Cox regression analysis demonstrated that a post-CRT PET SUV equal to or greater than 4 was an independent predictor of survival (HR, 3.5, p = 0.04). Conclusions The FDG-PET SUV is the most accurate noninvasive test to predict long-term survival after preoperative CRT and before surgical resection. Post-CRT FDG-PET cannot, however, rule out residual microscopic disease so esophagectomy should remain a therapeutic option even if the post-CRT imaging modalities are normal.

Original languageEnglish (US)
Pages (from-to)1152-1160
Number of pages9
JournalAnnals of Thoracic Surgery
Issue number4
StatePublished - Oct 2004


  • 7

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery


Dive into the research topics of 'Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer'. Together they form a unique fingerprint.

Cite this